title: Retrospective analysis of 99 patients with the application of extracorporeal membrane oxygenation in Fuwai Hospital.
abstract: The purpose of this study was to retrospectively summarize and analyze the data of 99 cases with the application of consecutive extracorporeal membrane oxygenation (ECMO) from December 2004 to August 2008 in Fuwai Hospital. The intersurface of the ECMO equipment system was completely heparin coated. All patients received venoarterial ECMO, and the activated clotting time was maintained between 120 and 180 seconds. The heparin dose was 5-20 U * kg(-1) * h(-1). Mean blood flow was 40-220 ml * kg(-1) * min(-1) during ECMO assisted period. The shortest ECMO time was 12 hours, and the longest was 504 hours (mean time, 119.45 +/- 80.20 hours). Sixty patients (60.6%) weaned from ECMO successfully; 54 of them (84%) were discharged, and six died of postoperative complications. Thirty-nine patients could not wean from ECMO. Total discharge rate was 54.5%. ECMO is an effective mechanical assistant therapy for cardiac and pulmonary failure after cardiac surgery. Earlier use of ECMO for heart lung failure patients and avoidance of irreversible damage to the main organs are still the key points in the success of ECMO.
authors.affiliation: Department of Cardiopulmonary Bypass, Peking Union Medical College, Chinese Academy of Medical Science, Fuwai Hospital, Beijing, China.
authors.forename: Yuan
authors.initials: Y
authors.lastname: Yuan
authors.forename: Guodong
authors.initials: G
authors.lastname: Gao
authors.forename: Cun
authors.initials: C
authors.lastname: Long
authors.forename: Feilong
authors.initials: F
authors.lastname: Hei
authors.forename: Jingwen
authors.initials: J
authors.lastname: Li
authors.forename: Jinping
authors.initials: J
authors.lastname: Liu
authors.forename: Zhengyi
authors.initials: Z
authors.lastname: Feng
authors.forename: Kun
authors.initials: K
authors.lastname: Yu
authors.forename: Ju
authors.initials: J
authors.lastname: Zhao
authors.forename: Shuyi
authors.initials: S
authors.lastname: Lrou
authors.forename: Shengshou
authors.initials: S
authors.lastname: Hu
authors.forename: Qian
authors.initials: Q
authors.lastname: Chang
authors.forename: Yinglong
authors.initials: Y
authors.lastname: Liu
authors.forename: Jianping
authors.initials: J
authors.lastname: Xu
authors.forename: Xu
authors.initials: X
authors.lastname: Wang
authors.forename: Ping
authors.initials: P
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002681:China; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods*; D005260:Female; D006333:Heart Failure / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult